1-17 of 17
Peter A. Riedell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

Open Access
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede, Farrukh T Awan, Veronika Bachanova, Talha Badar, Merav Bar, Pere Barba, Amer M. Beitinjaneh, Amanda F. Cashen, Bhagirathbhai Dholaria, Umar Farooq, Jessica Foglesong, Siddhartha Ganguly, Peiman Hematti, LaQuisa C Hill, Michael D Jain, Tania Jain, Partow Kebriaei, Adam S Kittai, Frederick L. Locke, Premal D Lulla, Joseph P. McGuirk, Elena Mead, Alberto Mussetti, Taiga Nishihori, Amanda L Olson, Martina Pennisi, Miguel-Angel Perales, Praveen Ramakrishnan Geethakumari, Peter A. Riedell, Wael Saber, Roni Shouval, Elizabeth J. Shpall, Margarida Magalhaes-Silverman, Christopher S Strouse, Cameron J. Turtle, Anusha Valluripalli, Kitsada Wudhikarn, Marcelo C. Pasquini, Sairah Ahmed, Mohamed L Sorror
Journal: Blood Advances
Blood Adv bloodadvances.2024015599.
https://doi.org/10.1182/bloodadvances.2024015599
Published: 2025
Includes: Supplemental data
Journal Articles

Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

Open Access
Zachary D Epstein-Peterson, Anath Christopher Lionel, Ashlee Joseph, Esther Drill, Suheil Albert Atallah-Yunes, Taylor R Brooks, Elise A. Chong, Emeline R Chong, Jamie Dela Cruz, Matthew J Frank, Andrew Ip, Madiha Iqbal, Caron A. Jacobson, Manali Kamdar, Reem Karmali, Ofrat Beyar-Katz, Kami J Maddocks, Matthew J. Matasar, Daniel McLoughlin, Reid W Merryman, Javier Munoz, Rohin Navalekar, Joanna M Rhodes, Peter A. Riedell, Christine E Ryan, Gilles A. Salles, Craig S. Sauter, Yazeed Sawalha, Samanvaya Sharma, Roni Shouval, Navika Shukla, Dylan Therwhanger, Herman J van Besien, Ben Varon, Yucai Wang, Samuel Yamshon, Andrew D. Zelenetz, M. Lia Palomba, Preetesh Jain, Anita Kumar
Journal: Blood Advances
Blood Adv bloodadvances.2025016315.
https://doi.org/10.1182/bloodadvances.2025016315
Published: 2025
Includes: Supplemental data
Journal Articles

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

Open Access
Clinical Trials & Observations
Kirk E. Cahill, James K. Godfrey, Chadi Nabhan, Justin Kline, Peter A. Riedell, Kenneth S. Cohen, Sunil Narula, Theodore G. Karrison, Jessica Robertson, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Seung Tae Lee, Jennie Y. Law, Paul A.S. Fishkin, Iris Isufi, Mario Reyes Velasco, Jr, Lynne Kaminer, Sonali M. Smith
Journal: Blood Advances
Blood Adv bloodadvances.2025017092.
https://doi.org/10.1182/bloodadvances.2025017092
Published: 2025
Includes: Supplemental data
Journal Articles

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

Open Access
Clinical Trials & Observations
Alison Sehgal, Daanish Hoda, Peter A. Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C. Hildebrandt, John E. Godwin, Patrick M. Reagan, Nina D. Wagner-Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K. Gupta, Victor A. Chow, Brenda Yuan, Zhi Yang, Ken Ogasawara, Jerill Thorpe, Leo I. Gordon
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3694–3705.
https://doi.org/10.1182/bloodadvances.2024015262
Published: 2025
Includes: Supplemental data
Journal Articles

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis

Open Access
Clinical Trials & Observations
Peter A. Riedell, Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna, Nausheen Ahmed, Richard T. Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J. Schuster, Andy I. Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P. McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter
Journal: Blood Advances
Blood Adv (2025) 9 (5): 1232–1241.
https://doi.org/10.1182/bloodadvances.2024014164
Published: 2025
Includes: Supplemental data
Journal Articles

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Free
Nausheen Ahmed, William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanova, Loretta J. Nastoupil, Miguel-Angel Perales, Richard T. Maziarz, Jamie Brower, Gunjan L. Shah, Andy I. Chen, Olalekan O. Oluwole, Stephen J. Schuster, Michael R. Bishop, Joseph P. McGuirk, Peter A. Riedell
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5346–5354.
https://doi.org/10.1182/bloodadvances.2023012549
Published: 2024
Includes: Supplemental data
Journal Articles

Optimization of older adults by a geriatric assessment–guided multidisciplinary clinic before CAR T-cell therapy

Free
Samuel J. Yates, John F. Cursio, Andrew Artz, Keriann Kordas, Michael R. Bishop, Benjamin A. Derman, Satyajit Kosuri, Peter A. Riedell, Justin Kline, Andrzej Jakubowiak, Mylove Mortel, Shalitha Johnson, Mariam T. Nawas
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3785–3797.
https://doi.org/10.1182/bloodadvances.2024012727
Published: 2024
Journal Articles

CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience

Free
Clinical Trials & Observations
Gulrayz Ahmed, Aseel Alsouqi, Aniko Szabo, Laura Samples, Mazyar Shadman, Farrukh T. Awan, Alexandra E. Rojek, Peter A. Riedell, Madiha Iqbal, Timothy S. Fenske, Mohamed A. Kharfan-Dabaja, Sawa Ito, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3528–3531.
https://doi.org/10.1182/bloodadvances.2023012255
Published: 2024
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Free
Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

Free
Clinical Trials & Observations
Michael Scordo, Jessica R. Flynn, Mithat Gonen, Sean M. Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L. Porter, Stephen J. Schuster, Veronika Bachanova, Joseph Maakaron, Richard T. Maziarz, Andy I. Chen, Loretta J. Nastoupil, Joseph P. McGuirk, Olalekan O. Oluwole, Andrew Ip, Lori A. Leslie, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5579–5585.
https://doi.org/10.1182/bloodadvances.2023010302
Published: 2023
Includes: Supplemental data
Journal Articles

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

Free
Shakthi T. Bhaskar, Vivek G. Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel-Angel Perales, Ana Alarcon Tomas, Michael R. Bishop, Joseph P. McGuirk, Richard T. Maziarz, Andy I. Chen, Veronika Bachanova, Joseph E. Maakaron, Peter A. Riedell, Olalekan O. Oluwole
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4765–4772.
https://doi.org/10.1182/bloodadvances.2022008937
Published: 2023
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Free
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data
Journal Articles

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Free
Clinical Trials & Observations
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R. Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanova, Loretta J. Nastoupil, Joseph P. McGuirk, Richard T. Maziarz, Olalekan O. Oluwole, Stephen J. Schuster, David L. Porter, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3192–3198.
https://doi.org/10.1182/bloodadvances.2022008294
Published: 2023
Includes: Supplemental data
Journal Articles

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Free
Yazeed Sawalha, Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, I. Brian Greenwell, Brian T. Hess, Krista M. Isaac, Craig A. Portell, Alex Mejia Garcia, Scott Goldsmith, Natalie S. Grover, Peter A. Riedell, Reem Karmali, Madelyn Burkart, Michael Buege, Othman Akhtar, Pallawi Torka, Anita Kumar, Brian T. Hill, Brad S. Kahl, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2983–2993.
https://doi.org/10.1182/bloodadvances.2022008916
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results

Free
Clinical Trials & Observations
Ulrich Jaeger, Nina Worel, Joseph P. McGuirk, Peter A. Riedell, Isabelle Fleury, Yan Du, Xia Han, David Pearson, Santiago Redondo, Edmund K. Waller
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2283–2286.
https://doi.org/10.1182/bloodadvances.2022007779
Published: 2023
Includes: Supplemental data
Journal Articles

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

Free
Clinical Trials & Observations
James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew Artz, Peter A. Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkataraman, Alan Cooper, Sonali M. Smith, Michael R. Bishop, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (6): 963–970.
https://doi.org/10.1182/bloodadvances.2022008403
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT

Free
Clinical Trials & Observations
Misha C. Tran, Yasmin Hasan, Amy Wang, Kamil Yenice, Julien Partouche, Wendy Stock, Richard A. Larson, Satyajit Kosuri, James L. LaBelle, Justin Kline, Peter A. Riedell, Andrew S. Artz, Ralph Weichselbaum, Michael R. Bishop, Bulent Aydogan, Hongtao Liu
Journal: Blood Advances
Blood Adv (2023) 7 (3): 285–292.
https://doi.org/10.1182/bloodadvances.2022007530
Published: 2023
Includes: Supplemental data